Literature DB >> 16782431

Regeneration and function of hemiliver graft: right versus left.

Nobuhisa Akamatsu1, Yasuhiko Sugawara, Sumihito Tamura, Hiroshi Imamura, Norihiro Kokudo, Masatoshi Makuuchi.   

Abstract

BACKGROUND: A right liver graft used almost routinely for adult living donor liver transplantation (LDLT), is associated with a higher incidence of morbidity and mortality in the donor. We compared volume regeneration and graft function between left and right liver grafts to examine the feasibility of using left liver grafts.
METHODS: The left liver was considered acceptable as a graft when it was estimated to be over 40% of the recipient standard liver volume. Otherwise, right liver harvesting was used, provided the estimated right liver volume was less than 70% of the donor's standard liver volume. Graft volume on computed tomography and the results of liver function tests 1, 3, and 12 months after LDLT were compared between recipients with left (n = 76) and right (n = 83) grafts. Possible factors influencing graft regeneration were evaluated by multivariate analysis.
RESULTS: A higher regeneration rate in the left liver graft group resulted in the same ratio of graft to standard liver volume as in the right liver graft group (88% vs 87%) 1 year after LDLT. Liver function tests and 5-year survival rates were comparable between the 2 groups. An episode of acute rejection was a predictive factor for impaired graft regeneration 1 month after LDLT. The initial ratio of graft volume to standard liver volume was an independent factor for regeneration 1 year after LDLT.
CONCLUSIONS: A properly evaluated left liver graft can be used as safely as a right liver graft in adult-to-adult LDLT. The findings of the present study justify LDLT with a left liver graft under specific selection criteria and may be preferred to a right liver graft.

Entities:  

Mesh:

Year:  2006        PMID: 16782431     DOI: 10.1016/j.surg.2005.12.011

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver.

Authors:  Arun Thenappan; Ying Li; Krit Kitisin; Asif Rashid; Kirti Shetty; Lynt Johnson; Lopa Mishra
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

2.  Comparison of liver regeneration between donors and recipients after adult right lobe living-donor liver transplantation.

Authors:  Yuling Zhang; Bei Li; Qing He; Zhiqiang Chu; Qian Ji
Journal:  Quant Imaging Med Surg       Date:  2022-06

3.  Chances and risks in living donor liver transplantation.

Authors:  Jessica Walter; Martin Burdelski; Dieter C Bröring
Journal:  Dtsch Arztebl Int       Date:  2008-02-08       Impact factor: 5.594

Review 4.  Liver stem cells and hepatocellular carcinoma.

Authors:  Lopa Mishra; Tanuj Banker; Joseph Murray; Stephen Byers; Arun Thenappan; Aiwu Ruth He; Kirti Shetty; Lynt Johnson; E P Reddy
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

5.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.

Authors:  Yi Tang; Krit Kitisin; Wilma Jogunoori; Cuiling Li; Chu-Xia Deng; Susette C Mueller; Habtom W Ressom; Asif Rashid; Aiwu Ruth He; Jonathan S Mendelson; John M Jessup; Kirti Shetty; Michael Zasloff; Bibhuti Mishra; E P Reddy; Lynt Johnson; Lopa Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

6.  A Minimal Physiologically-Based Pharmacokinetic Model for Tacrolimus in Living-Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype.

Authors:  Kotaro Itohara; Ikuko Yano; Tetsunori Tsuzuki; Miwa Uesugi; Shunsaku Nakagawa; Atsushi Yonezawa; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto; Kazuo Matsubara
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.